Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Langmuir ; 25(18): 11105-11, 2009 Sep 15.
Article in English | MEDLINE | ID: mdl-19735154

ABSTRACT

In the context of the electrocatalytic hydrogenation (ECH) process of unsaturated organic molecules, we have shown using infrared spectroscopy and water contact angle measurements that catalysts powders made of palladium on conductive tin dioxide (10% Pd/SnO2:F) and on alumina (10% Pd/Al2O3) are functionalized with organic chains when they were dipped in supporting electrolyte aqueous solutions containing different carboxylic acids. The carboxylic acids are bound to the supports (SnO2:F and Al2O3) through either the carboxyl or carboxylate groups. The measurement of contact angles confirmed that the support surface is functionalized by the carboxylic acids but also indicated the hydrophobic or hydrophilic character of the resultant surface. With these functionalized catalysts, the effectiveness of electrocatalytic hydrogenation of phenol could be modulated by controlling the adsorption of phenol. The adsorption depends mainly on the functionalization agent (carboxylic acid) and to a lesser extent on the identity of the support material (SnO2:F or Al2O3). Because adsorption is the step that induces the selectivity of the ECH process, controlling this phenomenon by functionalizing the catalyst support in situ is promising for obtaining molecules of choice.

2.
Bioorg Med Chem Lett ; 15(15): 3609-10, 2005 Aug 01.
Article in English | MEDLINE | ID: mdl-15967662

ABSTRACT

We have developed a concise synthesis of dielsiquinone 1, a potent cytotoxic agent related to anthraquinones. Electrochemical studies have shown that dielsiquinone is reduced to a semiquinone radical that does not react with O2 to generate toxic reactive oxygen species. These results strongly suggest that 1 should be less cardiotoxic than anthracyclines used in clinic and may therefore provide the basis for the development of safer anticancer drugs.


Subject(s)
Anthraquinones/chemical synthesis , Antibiotics, Antineoplastic/chemical synthesis , Aza Compounds/chemistry , Animals , Anthracyclines/pharmacology , Anthracyclines/toxicity , Anthraquinones/pharmacology , Antibiotics, Antineoplastic/pharmacology , Aza Compounds/chemical synthesis , Aza Compounds/pharmacology , Benzoquinones/chemistry , Oxygen/chemistry , Potentiometry/methods , Reactive Oxygen Species/chemistry , Reactive Oxygen Species/toxicity , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL
...